Supplementary Material for: A rare case of hemolytic anemia after alectinib that did not recur after switching to lorlatinib
We would like to share the case of a 55 year old male patient with ALK-positive lung cancer with a corpuscular hemolytic anemia following alectinib therapy. Approximately seven weeks after initiating alectinib therapy, this patient developed anemia. Laboratory tests revealed a new Coombs-negative he...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , |
| منشور في: |
2025
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|